Patrick Soon-Shiong Announced Plans for Tokenized Stocks

Nant aims to launch a blockchain-enabled platform for trading tokenized U.S. securities.

Updated on Sept. 21, 2026 in Biotech

Isometric editorial illustration showing crystalline geometric tokens on a minimalist plinth, representing blockchain-enabled financial settlement infrastructure. — Nant has announced plans for a new blockchain-settlement platform, leveraging a five-year SEC Innovation Exemption to facilitate the trading of tokenized U.S. equities. AI Illustration. Upload story photo >

Live Poll

Do you trust that tokenized stock trading will be as safe as traditional stock exchanges?

Patrick Soon-Shiong has announced that Nant will launch a new capital-markets platform featuring blockchain-settlement and tokenized stock capabilities. This development follows the SEC's creation of a five-year Innovation Exemption for trading tokenized U.S. equities.

Why it matters

The initiative leverages new regulatory pathways that allow for the tokenization of U.S.-listed securities. This move could fundamentally change how assets are settled and traded, positioning Nant to integrate blockchain technology directly into the capital markets ecosystem.

Nant is assembling comprehensive infrastructure through the acquisition of broker-dealer, transfer-agent, and exchange capabilities. The SEC framework requires platforms using third-party tokens to notify the issuing company 30 days before any listing occurs.

The players

Patrick Soon-Shiong

He is a prominent businessman and owner of 65.5% of ImmunityBio shares.

Nant

This is a global firm currently acquiring exchange and blockchain-settlement capabilities.

ImmunityBio

This is a biotech company that has seen its stock value rise 328% year-to-date.

SEC

The federal agency created a five-year Innovation Exemption for tokenized stock trading.

The details

Nant is consolidating essential market functions, including blockchain-settlement, to facilitate its platform goals. Investors are speculating that tokenization for ImmunityBio could occur within six to eight weeks, further highlighting the rapid integration of these new digital financial tools.

January 2026: Nant Global Finance announced its capital-markets platform.
April 2026: The proxy record date for ImmunityBio ownership was established.
September 20, 2026: Patrick Soon-Shiong announced plans for blockchain and tokenized stocks.
September 2026: Nant Capital led a private placement for PDS Biotechnology.

The Tech Race

This move signals a broader transition toward decentralized finance models within traditional stock markets. It positions Nant against legacy brokerage systems by replacing standard clearing houses with blockchain-based settlement technology.

Retail traders may soon access tokenized versions of U.S. stocks, potentially enabling faster settlement and new trading flexibility. Investors should monitor for mandatory 30-day notifications that issuers receive before any new tokenized listing appears on the platform.

The takeaway

Tokenization represents a significant shift in how securities move through the financial system by replacing conventional settlement delays with blockchain verification. As these platforms launch, retail participants should carefully evaluate the regulatory protections afforded by the SEC exemption.